Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Allogeneic Versus Autologous Transplantation in Multiple Myeloma: Reduced Relapse at the Cost of Higher Non-Relapse Mortality in a Large Single-Center Cohort
Tanaz Sayar Bahri
Tanaz Sayar Bahri

Assistant Professor of Internal Medicine

Department Internal Medicine

School of Medicine

Shariati Hospital

Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center

Tehran University of Medical Sciences

All Documents
1. Age-Related Considerations in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia: A 10-Year Retrospective Study, International Journal of Hematology-Oncology and Stem Cell Research (2025)
2. Evaluating the Safety and Feasibility of Prophylactic Third-Party Nk Cell Administration in High-Risk Aml Patients Post-Hsct, BMC Cancer (2025)
3. Hybrid Ganciclovir/Valacyclovir Prophylaxis Reduces Cmv Reactivation in High-Risk Allogeneic Stem Cell Transplant Recipients, International Journal of Hematology-Oncology and Stem Cell Research (2025)
4. Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia Patients Who Underwent Myeloablative Tbi-Free Conditioning Regimen, Leukemia and Lymphoma (2025)
5. Prophylactic Infusion of Donor Derived Cmv Specific T Cells for the Prevention of Cmv Reactivation Following Allogeneic Hsct, Scientific Reports (2025)
6. Corrigendum: Determining the Predictive Impact of Donor Parity on the Outcomes of Human Leukocyte Antigen Matched Hematopoietic Stem Cell Transplants: A Retrospective, Single-Center Study(Front. Oncol., (2024), 14, (1339605), 10.3389/Fonc.2024.1339605), Frontiers in Oncology (2024)
7. Determining the Predictive Impact of Donor Parity on the Outcomes of Human Leukocyte Antigen Matched Hematopoietic Stem Cell Transplants: A Retrospective, Single-Center Study, Frontiers in Oncology (2024)
8. Efficacy and Safety of Adoptive T-Cell Therapy in Treating Cytomegalovirus Infections Post-Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis, Reviews in Medical Virology (2024)
9. Clinical Features and Risk Factors of Relapse and Mortality in Thrombotic Thrombocytopenic Purpura Patients: A Seven-Year Experience, International Journal of Hematology-Oncology and Stem Cell Research (2023)
10. Three Doses of a Recombinant Conjugated Sars-Cov-2 Vaccine Early After Allogeneic Hematopoietic Stem Cell Transplantation: Predicting Indicators of a High Serologic Response—A Prospective, Single-Arm Study, Frontiers in Immunology (2023)
11. Outcomes of Haploidentical Peripheral Stem Cell Transplantation With Combination of Post-Transplant Cyclophosphamide (Ptcy) and Anti-Thymocyte Globulin (Atg) Compared to Unrelated Donor Transplantation in Acute Myeloid Leukemia: A Retrospective 10-Year Experience, Leukemia Research (2022)
12. Peripheral Blood Stem Cell Transplantation From Haploidentical and Unrelated Versus Related Donors for Acute Leukemia in Children, Adolescents and Young Adults (Caya): A Competing Risk Analysis, Cellular Therapy and Transplantation (2022)
13. Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare Between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation, International Journal of Hematology-Oncology and Stem Cell Research (2021)
14. Guidance for Facing Dilemmas of Hematopoietic Stem Cell Transplant Clinicians in the Covid-19 Pandemic: An Iranian Consensus, Mediterranean Journal of Hematology and Infectious Diseases (2020)